ARTICLE | Clinical News
CardioFit system: Phase III started
May 2, 2011 7:00 AM UTC
BioControl began the open-label, U.S. and German Phase III INOVATE-HF trial to evaluate CardioFit plus standard of care (SOC) vs. SOC alone in about 650 patients. ...